Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sherman Matthew L
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   197,506    

Indirect Shares

   8,500      
Direct Value   $15,072,557    

Indirect Value

   $1,519,375      
Total Shares   206,006      
Total Value   $16,591,932      


Acceleron Pharma Inc $12,292,101 Pulmatrix Inc $0 Deciphera Pharmaceuticals, Inc. $2,780,456 Acceleron Pharma Inc $12,292,101 Pulmatrix Inc $0 Deciphera Pharmaceuticals, Inc. $2,780,456
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    13    

     Stock price went up :
    0   
    8    
     Stock price went down :
    0   
    5    
   
     Gain/Loss Ratio :
   0.0   
   1.6   
     Percentage Gain/Loss :
     0.0%
 377.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Acceleron Pharma Inc XLRN EVP & Chief Medical Of... 2018-04-03 68,767 2018-04-03 8,500    Premium*  
            Pulmatrix Inc PULM Director 2018-04-03 20,000 2018-04-03 0    Premium*  
            Deciphera Pharmaceuticals, Inc. DCPH 2024-02-16 108,739 2019-10-15 0    Premium*  
* Premium Members only  

Records found :    122         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
XLRN Acceleron Pharma Inc EVP & Chief Medical Officer   •       –      –    2015-03-04 4 AS $40.63 $57,223 I/I (1,400) 17,700 0 -
XLRN Acceleron Pharma Inc EVP & Chief Medical Officer   •       –      –    2015-05-18 4 AS $32.20 $45,080 I/I (1,400) 14,100 0 -
XLRN Acceleron Pharma Inc EVP & Chief Medical Officer   •       –      –    2015-06-18 4 AS $31.07 $43,998 I/I (1,400) 12,700 0 -
XLRN Acceleron Pharma Inc EVP & Chief Medical Officer   •       –      –    2015-08-18 4 AS $30.99 $43,910 I/I (1,400) 10,100 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-05-28 4 AS $30.99 $46,485 I/I (1,500) 34,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-06-11 4 AS $33.25 $49,875 I/I (1,500) 33,000 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-07-09 4 AS $28.77 $43,499 I/I (1,500) 31,000 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-08-14 4 AS $29.82 $44,730 I/I (1,500) 29,000 0 -
XLRN Acceleron Pharma Inc EVP & Chief Medical Officer   •       –      –    2015-09-16 4 AS $32.22 $52,493 D/D (1,600) 96,404 0 -
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2023-06-16 4 S $14.40 $23,835 D/D (1,655) 87,686 0 %
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2020-02-18 4 A $0.00 $0 D/D 1,760 36,760 0 -
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2022-06-16 4 S $10.75 $19,006 D/D (1,768) 76,884 0 %
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-05-19 4 AS $31.47 $63,016 D/D (2,000) 15,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-05-19 4/A AS $31.47 $63,016 D/D (2,000) 13,922 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-06-18 4 AS $34.49 $68,980 D/D (2,000) 13,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-07-18 4 AS $26.39 $52,793 D/D (2,000) 11,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-08-18 4 AS $29.53 $59,060 D/D (2,000) 27,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-17 4 OE $3.88 $7,760 D/D 2,000 20,004 0 -
XLRN Acceleron Pharma Inc EVP & Chief Medical Officer   •       –      –    2017-01-04 4 AS $26.81 $54,916 D/D (2,000) 96,500 0 -
XLRN Acceleron Pharma Inc EVP & Chief Medical Officer   •       –      –    2016-04-06 4 AS $32.00 $66,560 D/D (2,080) 95,524 0 -
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2023-10-30 4 S $12.02 $28,362 D/D (2,360) 90,628 0 %
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2023-01-17 4 S $21.24 $51,043 D/D (2,403) 72,628 0 %
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2024-01-16 4 S $14.47 $35,234 D/D (2,435) 94,079 0 %
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2022-10-03 4 S $18.73 $48,455 D/D (2,587) 74,297 0 %
DCPH Deciphera Pharmaceuticals... EVP & Chief Medical Officer   •       –      –    2024-02-16 4 S $15.62 $40,840 D/D (2,615) 108,739 0 %
  122  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us